Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

4D Molecular Therapeutics, Inc. - Common Stock (NQ:FDMT)

12.16 -0.46 (-3.61%)
Delayed Quote Updated: 3:26 PM EDT, Oct 22, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 770,691
Open 12.60
Bid (Size) 12.15 (300)
Ask (Size) 12.18 (600)
Prev. Close 12.62
Today's Range 12.15 - 13.12
52wk Range 6.960 - 16.93
Shares Outstanding 42,052,980
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
4D Molecular Therapeutics Targets Wet AMD Injection Burden With 4D-150 Gene Therapy ↗
4D Molecular Therapeutics (NASDAQ:FDMT) used its first Investor Day to outline its development and commercial plans for 4D-150, an investigational intravitreal gene therapy for wet age-related macular... 
Via MarketBeat
News headline image
4DMT Announces New Employment Inducement Grants
From 4D Molecular Therapeutics, Inc.
Via GlobeNewswire

Performance

52-Week Range 28.1% below 52-week high
12.16
6.9652W Low 16.9352W High
1 Week 9.6% below 1-week high
12.001W Low 13.451W High

4D Molecular Therapeutics, Inc. - Common Stock (FDMT) traded between $6.96 and $16.93 over the past 52 weeks and last traded at $12.16, 28.1% below its 52-week high. Over the past week it ranged between $12.00 and $13.45.

Past 12 Months
-5.5%
-20.2%
+11.0%
+24.1%
+66.2%
+8.2%
1W -$0.71
1M -$3.08
3M +$1.20
6M +$2.36
YTD +$4.84
1Y +$0.92

FDMT was +8.2% over the past year, +24.1% over six months, +66.2% year to date, -5.5% in the last week.

12 Months vs Market
FDMT
+8.2%
DIA
+12.3%
SPY
+13.6%
QQQ
+15.1%
IWM
+11.9%

Over the past 12 months FDMT returned +8.2% versus DIA (Dow) +12.3%, SPY (S&P 500) +13.6%, QQQ (Nasdaq 100) +15.1% and IWM (Russell 2000) +11.9%.

Volume & Liquidity 0.81× 3-mo avg
Today 770,691 3-mo avg 955.5K
1W
1.0M
1M
1.1M
3M
955.5K
6M
910.3K
YTD
860.5K
1Y
896.4K

FDMT most recently traded 770,691 shares against a 3-month average daily volume of 955.5K.

More News

Read More
News headline image
4DMT to Host Investor Day on October 21, 2026
From 4D Molecular Therapeutics, Inc.
Via GlobeNewswire
4D Molecular Therapeutics (NASDAQ:FDMT) Q1 2026: Revenue Miss and Wider Losses Overshadow Phase 3 Progress ↗
Via Chartmill
News headline image
4DMT Advances 4D-150 into Phase 3 for Second Large Market Retina Indication with Initiation of 4SIGHT in DME
From 4D Molecular Therapeutics, Inc.
Via GlobeNewswire
News headline image
4DMT Announces New Employment Inducement Grants
From 4D Molecular Therapeutics, Inc.
Via GlobeNewswire
News headline image
4DMT to Participate in Upcoming Investor Conferences
From 4D Molecular Therapeutics, Inc.
Via GlobeNewswire
News headline image
4DMT Announces New Employment Inducement Grants
From 4D Molecular Therapeutics, Inc.
Via GlobeNewswire
News headline image
4DMT Reports Second Quarter 2026 Financial Results, Operational Highlights and Expected Upcoming Milestones
From 4D Molecular Therapeutics, Inc.
Via GlobeNewswire
News headline image
4DMT Announces Positive 2-Year Data from PRISM Phase 2b Clinical Trial in a Broad Wet AMD Population
From 4D Molecular Therapeutics, Inc.
Via GlobeNewswire
News headline image
4DMT Announces New Employment Inducement Grants
From 4D Molecular Therapeutics, Inc.
Via GlobeNewswire
News headline image
4DMT Announces Presentation at 44th Annual Scientific Meeting of the American Society of Retina Specialists
From 4D Molecular Therapeutics, Inc.
Via GlobeNewswire
News headline image
4DMT Completes Enrollment for 4FRONT-2 Global Phase 3 Clinical Trial of 4D-150 in Wet AMD
From 4D Molecular Therapeutics, Inc.
Via GlobeNewswire
News headline image
4DMT Secures Strategic Credit Facility for up to $200 Million from Hercules Capital
From 4D Molecular Therapeutics, Inc.
Via GlobeNewswire
News headline image
4DMT Announces New Employment Inducement Grants
From 4D Molecular Therapeutics, Inc.
Via GlobeNewswire
News headline image
4DMT to Participate in Upcoming Investor Conferences
From 4D Molecular Therapeutics, Inc.
Via GlobeNewswire
News headline image
4D Molecular Therapeutics Touts Rapid Phase 3 Momentum for Retinal Gene Therapy ↗
Via MarketBeat
News headline image
4DMT Announces New Employment Inducement Grants
From 4D Molecular Therapeutics, Inc.
Via GlobeNewswire
News headline image
4DMT Reports First Quarter 2026 Financial Results, Operational Highlights and Expected Upcoming Milestones
From 4D Molecular Therapeutics, Inc.
Via GlobeNewswire
News headline image
4DMT to Participate in Upcoming Investor Conferences
From 4D Molecular Therapeutics, Inc.
Via GlobeNewswire
News headline image
4DMT Reports Full Year 2025 Financial Results, Operational Highlights and Expected Upcoming Milestones
From 4D Molecular Therapeutics, Inc.
Via GlobeNewswire
News headline image
4DMT to Participate in Upcoming Investor Meetings
From 4D Molecular Therapeutics, Inc.
Via GlobeNewswire
News headline image
4DMT to Participate in Upcoming Investor Conferences
From 4D Molecular Therapeutics, Inc.
Via GlobeNewswire
News headline image
4DMT Announces New Employment Inducement Grants
From 4D Molecular Therapeutics, Inc.
Via GlobeNewswire
News headline image
4DMT Completes Enrollment for 4FRONT-1 Phase 3 Clinical Trial of 4D-150 in Wet AMD
From 4D Molecular Therapeutics, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is 4D Molecular Therapeutics, Inc. - Common Stock publicly traded?
Yes, 4D Molecular Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does 4D Molecular Therapeutics, Inc. - Common Stock trade on?
4D Molecular Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for 4D Molecular Therapeutics, Inc. - Common Stock?
The ticker symbol for 4D Molecular Therapeutics, Inc. - Common Stock is FDMT on the Nasdaq Stock Market
What is the current price of 4D Molecular Therapeutics, Inc. - Common Stock?
The current price of 4D Molecular Therapeutics, Inc. - Common Stock is 12.16
When was 4D Molecular Therapeutics, Inc. - Common Stock last traded?
The last trade of 4D Molecular Therapeutics, Inc. - Common Stock was at 10/22/26 03:26 PM ET
What is the market capitalization of 4D Molecular Therapeutics, Inc. - Common Stock?
The market capitalization of 4D Molecular Therapeutics, Inc. - Common Stock is 511.57M
How many shares of 4D Molecular Therapeutics, Inc. - Common Stock are outstanding?
4D Molecular Therapeutics, Inc. - Common Stock has 512M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.